After EPS-1 administration, the reduced expressions of claudin-1, occludin, and E-canherin proteins were counteracted (Figure 4A,B), which provided another powerful evidence for the protective effects of EPS-1 on mice colitis. The gene discussed is CLDN1; the disease is colitis.